Sciencast Management’s Frontline FRO Stock Holding History

Sciencast Management’s Portfolio FRO Stock Details FRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-137,554	Closed	-$3M	–	321
2025 Q4	$3M	Buy	+137,554	New	+$3.22M	0.42%	105
2020 Q1	–	Sell	-22,523	Closed	-$289K	–	409
2019 Q4	$289K	Buy	+22,523	New	+$245K	0.08%	368

Other funds holding FRO

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Sciencast Management's FRO Position: Q1 2026 in Review

Sciencast Management sold out of Frontline (FRO) in Q1 2026, closing a stake of 137,554 shares — an estimated $3M sold.

Sciencast Management first reported a position in FRO in Q4 2019 and held it in 2 quarters. The position peaked at $3M in Q4 2025. 241 funds tracked by Wall St. Rank hold FRO as of Q1 2026.

Sciencast Management reported no remaining Frontline position as of Q1 2026 after selling out during the quarter.
Sciencast Management sold 137,554 Frontline shares in Q1 2026, an estimated $3M.
Sciencast Management first reported a position in Frontline in Q4 2019 and held it in 2 quarters.
Sciencast Management's Frontline position peaked at $3M in Q4 2025.
241 funds tracked by Wall St. Rank held Frontline as of Q1 2026.

Based on Sciencast Management's 13F filing for Q1 2026, filed 14 May 2026.